Short-Term Pharmacological Induction of Arterial Stiffness and Hypertension with Angiotensin II Does Not Affect Learning and Memory and Cerebral Amyloid Load in Two Murine Models of Alzheimer’s Disease
Abstract:Given the unprecedented rise in the world’s population, the prevalence of prominent age-related disorders, like cardiovascular disease and dementia, will further increase. Recent experimental and epidemiological evidence suggests a mechanistic overlap between cardiovascular disease and dementia with a specific focus on the linkage between arterial stiffness, a strong independent predictor of cardiovascular disease, and/or hypertension with Alzheimer’s disease. In the present study, we investigated whether phar… Show more
“…Indeed, increased arterial stiffness causes an excessive pulsatile energy in the brain microvascular bed due to insufficient flow wave damping, thus promoting the onset of microbleeds [ 85 ]. Studies on murine models also showed that the short-term pharmacological induction of arterial stiffness does not cause additional effects on mouse models of Alzheimer, suggesting a pathogenetic role of long-lasting arterial stiffness [ 86 ]. Recent studies also reported a positive association between local amyloid-β and regional tau burden and aortic stiffness [ 84 ], but its exact cause–effect relation deserves further studies.…”
Section: Increased Arterial Stiffness and Clinical Outcomementioning
Aging of the vascular system is associated with deep changes of the structural proprieties of the arterial wall. Arterial hypertension, diabetes mellitus, and chronic kidney disease are the major determinants for the loss of elasticity and reduced compliance of vascular wall. Arterial stiffness is a key parameter for assessing the elasticity of the arterial wall and can be easily evaluated with non-invasive methods, such as pulse wave velocity. Early assessment of vessel stiffness is critical because its alteration can precede clinical manifestation of cardiovascular disease. Although there is no specific pharmacological target for arterial stiffness, the treatment of its risk factors helps to improve the elasticity of the arterial wall.
“…Indeed, increased arterial stiffness causes an excessive pulsatile energy in the brain microvascular bed due to insufficient flow wave damping, thus promoting the onset of microbleeds [ 85 ]. Studies on murine models also showed that the short-term pharmacological induction of arterial stiffness does not cause additional effects on mouse models of Alzheimer, suggesting a pathogenetic role of long-lasting arterial stiffness [ 86 ]. Recent studies also reported a positive association between local amyloid-β and regional tau burden and aortic stiffness [ 84 ], but its exact cause–effect relation deserves further studies.…”
Section: Increased Arterial Stiffness and Clinical Outcomementioning
Aging of the vascular system is associated with deep changes of the structural proprieties of the arterial wall. Arterial hypertension, diabetes mellitus, and chronic kidney disease are the major determinants for the loss of elasticity and reduced compliance of vascular wall. Arterial stiffness is a key parameter for assessing the elasticity of the arterial wall and can be easily evaluated with non-invasive methods, such as pulse wave velocity. Early assessment of vessel stiffness is critical because its alteration can precede clinical manifestation of cardiovascular disease. Although there is no specific pharmacological target for arterial stiffness, the treatment of its risk factors helps to improve the elasticity of the arterial wall.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.